BioBrit

Castle Biosciences develops genomic diagnostic tests that use a patient's molecular biology to inform disease management and treatment decisions.

BiotechDigital HealthHealthtechFriendswood, US

Derek Maetzold(Executive Officer, Director)inFrank Stokes(Chief Financial Officer)inKristen Oelschlager(Chief Operating Officer)inToby Juvenal(Chief Commercial Officer)inHillary Caruso(Chief of Staff)in

BoardMara Aspinall(Director)

Co-investorsIllumina VenturesMountain Group Capital

Compass Therapeutics uses proprietary antibody discovery platforms to generate and screen diverse panels of monoclonal and multispecific antibodies, aiming to identify synergistic therapeutic combinations.

BiotechHealthtechCambridge, US

Schuetz Thomas(Executive Officer, Director)inErrik Anderson(Executive Officer, Director)inThomas J. Schuetz(Executive Officer, Director)inVered Bisker-Leib(Executive Officer)in

BoardCarl L. Gordon(Director)Julie Sunderland(Director)

Co-investorsF-Prime CapitalForesite CapitalOrbiMedvenBio PartnersVivo Capital

Geron is a biopharmaceutical company focused on developing therapies for blood cancer.

BiotechHealthtechLongevityMedical Devices

Co-investorsNew Enterprise Associates (NEA)

Tyra is developing oral dabogratinib, a small-molecule therapy being evaluated in clinical studies for skeletal dysplasia and urologic cancers.

BiotechHealthtechCarlsbad, US

Todd Harris, Ph.D.(Executive Officer, Director)Hiroomi Tada, M.D., Ph.D.(Executive Officer)Daniel Bensen(Executive Officer)inAlan Fuhrman(Executive Officer)in

BoardRobert More(Director)Nina Kjellson(Director)in

Co-investorsAlta PartnersNextech InvestCanaan Partners

BiotechSan Diego, US

Douglas J. Jolly(Founder)inCarlos E. Ibanez(Executive Officer)Robert Anthony Williamson(Director)Troy Wilson(Director)Michael Martin(Director)Nicholas A. Boyle, Ph.D.(Executive Officer, Director)

A biopharmaceutical company with over 30 years of experience developing and commercializing treatments for central nervous system (CNS) diseases.

BiotechHealthtech

Co-investorsDag Ventures

Co-investorsSolas BioVentures

Alta Partners is a venture capital firm focused on life sciences and healthcare investments, with a portfolio that has generated over 90 FDA-approved products and includes both therapeutic companies and tech-enabled patient care services.

BiotechHealthtechMedical Devices

Jean DeleageGuy NohrainGarrett GruenerMarino Polestra

BiotechSan Diego, US

Francois Ferre(Director)Magda Marquet(Director)Jorge Garces(Executive Officer)inGreg Hamilton(Executive Officer, Director)Carin Sandvik(Executive Officer)Jeffrey G. Black(Executive Officer)

Co-investorsAlly Bridge GroupVivo CapitalWuXi Healthcare Ventures

Alume Biosciences develops nerve illumination technology for surgery, including bevonescein (ALM-488), an injectable peptide that makes nerves glow to help surgeons identify and preserve them during procedures such as head-and-neck and prostate surgery.

BiotechHealthtechMedical DevicesLa Jolla, US

Quyen Nguyen(Co-founder)inRoger Tsien(Co-founder)Kaveri Parker(Executive Officer)inBrett Berman(Executive Officer, Director)inJames Schmidt(Executive Officer)in

BoardKim Kamdar(Director)

Amplo Biotechnology develops adeno-associated virus (AAV) gene therapies for genetic diseases of the neuromuscular junction, targeting rare and ultra-rare patient populations such as those with Congenital Myasthenic Syndromes.

BiotechHealthtechPompano Beach, US

Al Hawkins(President / Program Director)Jean Kim(Director)Paul Hawkins(Executive Officer, Director)Terry Vance(Director)Matthew Pauls(Director)Patricio Sepulveda(Executive Officer, Director)in

Co-investorsKeiretsu ForumSofinnova Ventures

Aspen Biosciences provides consulting, advisory, and research resources focused on drug discovery and biopharmaceutical R&D, serving pharmaceutical and biotech companies navigating program management, digital transformation, and emerging technologies like AI.

AI & Machine LearningBiotechEnterprise SoftwareHealthtechSaaSSan Diego, US

Attralus develops pan-amyloid removal (PAR) therapeutics — biologics and imaging agents designed to bind and remove toxic amyloid — to treat patients with systemic amyloidosis across all disease types and stages.

BiotechHealthtechSouth San Francisco, US

Jonathan Wall(Executive Officer)inSpencer Guthrie(Executive Officer)Mark Timney(Executive Officer, Director)inBenson Fong(Executive Officer)Rahul Kakkar(Director)Greg Bell(Executive Officer)

Co-investorsAlpha Wave GlobalvenBio PartnersJanus Henderson InvestorsREDMILESamsara BioCapitalvenBio Global Strategic+1 more

Biolinq develops a non-invasive glucose sensor that uses light to display glucose levels in real time, while also tracking activity and sleep to provide personalized health insights via a mobile app.

BiotechDigital HealthHealthtechMedical DevicesSan Diego, US

Jared Tangney(Executive Officer, Director, Promoter)inRichard Yang(Executive Officer, Director)Edward Kliphuis(Director)

BoardDaniel Bradbury(Director)inLana Ghanem(Director)

Co-investorsAlpha Wave GlobalBeyond CapitalJDRF T1D FundAphelion CapitalHikma VenturesLifeSci Venture Partners+1 more

Exact Sciences develops and runs laboratory tests and clinical studies for cancer detection and treatment, serving patients and health care professionals in oncology.

BiotechDigital HealthMedical DevicesSan Diego, US

Tony Broad(Executive Officer)Francois Ferre(Director)Nick Ecos(Executive Officer, Director)Joseph Markee(Executive Officer, Director)

BioRock Ventures is a seed-stage venture capital fund that invests in private life science startups developing novel FDA-regulated therapeutic drugs across all disease areas and modalities.

Biotech

Co-investorsAtacama Ventures

CardioFocus develops Pulsed Field Ablation (PFA) technologies and systems for electrophysiologists to treat complex cardiac arrhythmias with precision and control.

BiotechHealthtechMedical DevicesMarlborough, US

Lauren Jennings(Executive Officer)Warren Clark(Executive Officer)Stephen Sagon(Executive Officer, Director)inAnjie Roldan(Executive Officer)inWarren R. Clark III(Executive Officer)Stephan S. Ogilvie(CEO)in

Co-investorsSV Health Investors

Creyon develops cell-specific therapeutics using aptamer-delivered oligonucleotides, engineering aptamers to deliver therapeutic payloads to immune cells and across the blood-brain barrier for immune-driven and CNS diseases, plus a splice-switching oligonucleotide program for late-onset Pompe disease.

AI & Machine LearningBiotechDeep Tech

Co-investorsDCVC (Data Collective)DCVC BioTenmile

CRISPR QC develops the CRISPR Analytics Platform, a graphene-based biosensor system that provides real-time quantitative kinetic measurements of RNP formation, DNA target binding, and CRISPR-Cas cleavage activity.

BiotechDeep TechHardwareSan Diego, US

Ross Bundy(Executive Officer, Director)inKiana Aran(Director)Michael Heltzen(Director)

BoardGeorge Bonaros(Director)Paul Grint(Director)Toby Richardson(Director)

Co-investorsSerra VenturesSuncoast Ventures

DelNova is a life science company developing proprietary assets in medical aesthetics and neuromuscular therapeutics, having advanced from early research into Series A financing.

BiotechHealthtechMedical DevicesHighland, US

Mary Gardner(Chief Executive Officer & Founder)inSameer B. Shah(Chief Scientist)Steven Yoelin(Chief Medical Strategist)Dimas Jimenez(Chief Financial Advisor)

BoardDaniel Bradbury(Director)

Ecor1 Capital is an investment firm with a team of professionals across portfolio management, analysis, operations, and investor relations.

BiotechDigital Health

Oleg Nodelman(Founder + Portfolio Manager)

Co-investorsAlpine MeridianSofinnova Ventures

Encoded develops gene therapies for neurological disorders through an integrated platform approach.

Biotech

Stephanie Tagliatela(Founder)in

Co-investorsARCH Venture PartnersGV (Google Ventures)Illumina VenturesMenlo VenturesSoftBank Vision FundVenrock

Co-investorsCota CapitalDecheng Capital

Non-invasive diagnostic tools for detecting and managing chronic diseases such as diabetes.

San Diego, US

John D Gerace(Executive Officer, Director)Craig Misrach(Director)

BoardDan Bradbury(Director)inAndy Sassine(Director)Lynn-Ann Gries(Director)James E. Pinkin(Director)

Co-investorsBootstrap Venture Partners

Genalyte develops Merlin, a real-time diagnostic system that performs laboratory testing directly in clinical settings and integrates results with electronic health records.

Digital HealthHardwareHealthtechMedical DevicesSan Diego, US

Cary Gunn(Co-founder and Chief Technical Officer)in

Co-investorsBoutique Venture PartnersClaremont Creek VenturesFusionX VenturesIPD CapitalSamsara BioCapitalSeed Healthcare+3 more

Hemostemix is a clinical-stage regenerative medicine company developing ACP-01, an investigational autologous (patient-derived) stem cell therapy for vascular and ischemic conditions such as critical limb ischemia, peripheral arterial disease, ischemic cardiomyopathy, and heart failure.

BiotechHealthtechLongevityMedical DevicesBlackfalds

Roger Bergersen(Founder (of predecessor TheraVitae Inc.))Thomas A. Smeenk(President & CEO, Co-Founder)inIna Sarel(VP, Research and Development)inKyle Makofka(Chief Restructuring Officer)inDavid Berman(Chief Financial Officer)Dr. Fraser Henderson(Chief Medical Officer)

In The Bowl Animal Health (ITBAH) develops and commercializes antiparasitics and therapeutics for pets by incorporating the drug directly into the pet's daily food to improve compliance and convenience.

BiotechConsumerFoodTechHealthtechNashville, US

Randolph Legg(Chief Executive Officer)inScott Holmstrom, Ph.D.(Chief Scientific Officer)Eric Graves(Director)Jay Ferguson(Executive Officer)Robin Readnour(Director)Diane Hirakawa(Director)

Co-investorsMountain Group Capital

Independa operates Health Hub, a HIPAA-compliant health and wellness platform for seniors that delivers telehealth, video calling, family communication, games, and fitness tools across TVs, tablets, computers, and phones.

Digital HealthHealthtechLongevitySan Diego, US

Kian Saneii(Founder & CEO)inJaye Connolly(Executive Officer)Richard Della Penna(Executive Officer)Gary Gilmore(Executive Officer)John Carrington(Director)

BoardMagda Marquet(Director)

Intercept Pharma develops therapeutics for rare liver diseases, focusing on cholestatic pruritus in Primary Biliary Cholangitis patients through IBAT inhibitor programs and bile acid biology research.

BiotechHealthtechMedical Devices

Co-investorsAisling CapitalRidgeback CapitalSamsara BioCapital

MD Revolution (CoachCare) provides remote care management technology and US-based clinical care services for healthcare practices, supporting programs such as remote patient monitoring, chronic care management, and behavioral health integration.

Digital HealthHealthtechSaaSSan Diego, US

Samir Damani(Executive Officer, Director)inArthur Roke(Executive Officer)Pratik Patel(Executive Officer)

BoardJean Balgrosky(Executive Officer, Director)inGarrett Vygantas(Director)Jacqueline Kosecoff(Director)

Co-investorsBootstrap Venture PartnersJump Capital

Medical Excellence Capital is a venture capital firm investing in early-stage life science and healthcare companies.

AI & Machine LearningBiotechFintechHealthtechNew York, US

John Prufeta(Chief Executive Officer and Managing Partner)Eric Heil(Managing Partner)Kim Kamdar(Managing Partner)Brian Halak(Managing Partner)Joni Mancini(Managing Partner)

Minutia develops insulin-producing cell transplants that can be monitored in vivo over time, aimed at improving cell replacement therapy for diabetes.

BiotechDeep TechDigital Health

Mirati develops investigational medicines and treatments for patients with multiple myeloma and other oncology indications.

BiotechHealthtechMedical Devices

Co-investorsAvoro Capital Advisors

Mountain Group Partners is a venture capital firm with 25 years of history that invests in disruptive technologies, diagnostics, medtech, animal health, and drug development across underserved sectors.

AI & Machine LearningBiotechHealthtechMedical DevicesNashville, US

Byron Smith(Co-founder & Managing Director)Joe Cook, III(Co-founder & Managing Director)Rob Readnour(Co-founder & Managing Director)Joe Cook, Jr.(Co-founder & Managing Director)

Telemynd is a mental healthcare platform that connects patients with licensed providers through a human-centered approach, prioritizing privacy and continuity of care while using technology to reduce administrative burden and improve access.

Digital HealthHealthtechMental HealthAliso Viejo, US

Paul Buck(Executive Officer)George Carpenter(Executive Officer)inPatrick Herguth(CEO)in

BoardZachary McAdoo(Director)Andrew Sassine(Director)John Pappajohn(Director)

Co-investorsFusionX Ventures

Dowds is a UK-based engineering company providing integrated technical solutions and design-led project delivery for complex built environments, with particular expertise in healthcare infrastructure, mechanical, electrical, and building systems integration.

Construction TechHealthtechUK, GB

Co-investorsAscension VenturesSignet Healthcare Partners

Ovid Therapeutics develops medicines for children and adults with epilepsies and brain conditions, focusing on anti-seizure and neurological treatments.

BiotechHealthtechMedical DevicesNew York, US

Jeremy M. Levin(Co-founder and Executive Chairman)inMeg Alexander(President & Chief Executive Officer)inCharles Carter(Chief Financial Officer)inVictoria Fort(Chief Strategy Officer)inPetra Kaufmann(Chief Medical Officer)inManal Morsy(Chief Regulatory Officer)in

Co-investorsSanofi Ventures

Persephone Biosciences develops a synbiotic (probiotic and prebiotic combination) supplement for infants designed to replenish key beneficial gut bacteria.

BiotechFemTechHealthtechSan Diego, US

Stephanie Culler(Founder/CEO)inStephen Van Dien(Founder/CTO)in

Co-investorsFifty YearsFirst Bight VenturesHemi Ventures, LlcOcampo CapitalY CombinatorDCVC (Data Collective)+1 more

Primmune Therapeutics develops PRTX007, an orally administered, systemically active TLR7 agonist that activates interferon-associated innate immune pathways for use in cancer immunotherapy.

BiotechHealthtechCarlsbad, US

James Appleman(SVP, R&D and CSO, Cofounder)Paulo Rangel(Chief Business Officer and Cofounder)inStephen Webber(Vice President, Medicinal Chemistry, and Cofounder)inCharles McDermott(President & CEO, Director)

BoardTodd J Harris(Director)

Co-investorsBioRock VenturesSamsara BioCapitalPolaris Partners

ProciseDx develops diagnostic technology, including a point-of-care testing platform, drawing on expertise in central lab instrumentation and point-of-care devices.

BiotechDigital HealthHealthtechMedical DevicesSan Diego, US

Larry Mimms(Executive Officer, Director)inMagda Marquet(Director)Martin Hendrix(Director)Larry Abensur(Director)Peter Westlake(Executive Officer, Director)

PTM Therapeutics is a biotechnology company developing therapeutic candidates.

BiotechMedical DevicesBedford, US

Jennifer C. Cheng(CEO/Co-Founder)Tony W. Liang(VP of Research/Co-Founder)inCharles A. Parkos(Scientific Co-Founder)Jennifer C. Brazil(Scientific Co-Founder)

Co-investorsBioRock Ventures

RayBalance develops a proprietary, non-reformulation platform that treats the subcutaneous injection administration site as a delivery-performance variable to improve absorption predictability without altering a partner's drug product.

BiotechDeep TechMedical DevicesSan Diego, US

Red Tree is a life science venture capital firm using a West Coast-focused, early-stage investment strategy.

Biotech

Renova Therapeutics develops investigational gene therapies intended as single-dose, long-lasting treatments for common chronic diseases, with an initial focus on congestive heart failure and type 2 diabetes.

BiotechHealthtechCarlsbad, US

Kirk Hammond(Director)Shawn Swaney(Executive Officer)in

BoardRoy Cosan(Director)Pierre Lecocq(Director)Vijay Mahant(Director)Michael Torres(Director)

RNAV8 Bio develops a toolkit for engineering mRNA therapeutics, optimizing non-coding sequences to improve expression and efficacy of mRNA-based treatments.

AI & Machine LearningBiotechLaguna Niguel, US

Devan ShahinMichelle Lynn Hall

Co-investorsElmehøj VenturesPortal InnovationsService Provider Capital

Samsara BioCapital is a venture capital firm that invests in therapeutic and biotech companies, backing scientific teams developing new drugs and medical treatments.

BiotechDeep Tech

Dr. Srinivas Akkaraju(Founder and Managing General Partner)

Co-investorsModi Ventures

San Diego, US

Co-investorsUlu Ventures

Sensulin is a preclinical biopharmaceutical company developing glucose-responsive insulin therapies for type 1 and type 2 diabetes that aim to reduce hypoglycemia risk and daily injection requirements.

BiotechMedical Devices

Dan Bradbury(Executive Chairman and Co-Founder)inMike Moradi(CEO)in

BoardAnanth AnnapragadainChristopher Rhodesin

Co-investorsCortado Ventures

Seraphina Therapeutics develops food- and nature-based consumer health products, starting with the fatty acid C15:0 (pentadecanoic acid), aimed at replenishing micronutrients and metabolites that decline with age.

ConsumerLongevityWellness & Fitness

Co-investors1315 Capital

Co-investorsMission BiocapitalNext Frontier Capital

Stuart Therapeutics is a clinical-stage pharmaceutical company developing synthetic collagen mimetic peptides (its PolyCol platform) designed to bind and repair damaged helical collagen in the extracellular matrix.

BiotechDeep TechHealthtech

Robert O. Baratta(Co-founder)Shawn DeLorey(Operations & Corporate Development (inventor of PolyCol))in

A company offering regenerative and aesthetic medical products for facial, breast, and body treatments across all stages of life.

HealthtechMedical DevicesSan Diego, US

Nicholas L. Teti, Jr.(Executive Officer, Director)Joseph A. Newcomb(Executive Officer)Stewart M. Brown(Executive Officer)in

BoardClarke B. Futch(Director)Paul J. Hadden(Director)Todd C. Davis(Director)

Co-investorsEssex Woodlands Healthcare Partners

Co-investorsAisling CapitalAvoro Capital AdvisorsDelos CapitalEcoR1 Capital